Netrin and its receptor Neogenin are thought to be regulators of axonal guidance in the nervous system. A recent report suggests they also play a role in epithelial morphogenesis. 
Netrins are a family of secreted glycoproteins that have been extensively studied as regulators of axonal guidance mediated through two different receptor families: the DCC receptor family, which includes Neogenin, and the UNC5H family of receptors [1] . Relatively little is known about Neogenin within the nervous system, and even less is known about the function of Netrin and Neogenin outside of the nervous system, despite their wide range of expression. A recent paper by Srinivasan et al. [2] describes the expression of Netrin-1 (Ntn-1) and Neogenin (Neo1) in the mouse mammary gland, and reports that glands developing from Ntn-1 or Neo1 mutant tissue are abnormal, suggesting an adhesive role for this receptor-ligand system during mammary gland morphogenesis.
Ntn-1 and Neo1 are expressed in mutually exclusive regions of the mammary terminal end buds, which are highly proliferative structures found at the invading edge of developing mammary glands (Figure 1 ). They first appear around birth in the mouse in response to maternal hormones. The mammary gland then remains in a static phase until puberty (~4 weeks of age) when terminal end buds re-appear and lead the mammary ductal invasion of the mammary fat pad [3] . Proliferation takes place in the outer cell layer of the terminal end bud, known as the cap cell layer. Cap cells proliferate and differentiate into both epithelial cells lining the mammary duct and myoepithelial cells which surround the ductal epithelium, and therefore represent a progenitor stem cell population. Once the terminal end buds reach the end of the fat pad, as yet unidentified signals instruct the terminal end buds to become quiescent, and they are replaced by terminal end ducts and alveolar buds.
Ntn-1 is produced by both ductal epithelial cells and prelumenal cells of the terminal end bud, where it is secreted and localized among the prelumenal cells, cap cells and immediately surrounding stroma [2] . Neo1 meanwhile is expressed exclusively on the surface of cap cells. Mice homozygous mutant for Ntn-1 or Neo1 die before the pubertal development of mammary glands, however mammary glands from Ntn-1 and Neo1 mutant embryos can be transplanted into the cleared fat pads of nude mice to allow continuing mammary development. Ntn-1 and Neo1 mutant mammary glands display the same phenotype: although able to form a full ductal network, the terminal end buds are disorganized with an enlarged subcapsular space containing loose cells, likely originating from the cap cell layer. Disruption of the basal lamina and increased apoptosis are also detected. To confirm that Ntn-1 and Neo1 play an adhesive role in the terminal end bud, an in vitro assay was performed with L1 cells expressing Neo1: Srinivasan et al. [2] found that the addition of netrin to the cell culture led to cell aggregation.
It is unclear if netrin-neogenin functions as an adhesive complex itself, or if it is an essential signaling component for adhesion. Neo1 is a member of a N-CAM-like cell surface receptor family [4] , while Ntn-1 shows significant sequence similarity to laminin and contains the integrin-binding RGD motif [5] . Experiments using function-blocking antibodies against β β1 integrin have shown that it is required for correct terminal end bud formation and mammary development, but there is no change in terminal end bud structure or levels of apoptosis [6] . Although Ntn-1 is a secreted protein, it is primarily localized on the cell surface and can also bind to the extracellular matrix (ECM) [7] . Ntn-1 bound to the cell surface of prelumenal cells immediately adjacent to the cap cells may directly bind to cap cell Neo1, forming an adhesive complex (Figure 2A) 
